EXTON, Pa., Aug. 17, 2017 /PRNewswire/ -- ACF Bioservices™ (an Absorption Systems ® company) announces the completion of construction on its dedicated cGMP-compliant 3400 square foot facility for gene ...

SEATTLE, March 05, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment ...

LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell ...

Our Cell Processing Facility (CPF) is a Good Manufacturing Practice, or GMP, bioprocessing manufacturing facility that supports the reproducible production of human hematopoietic or immune-competent ...

BOCA RATON, Fla.--(BUSINESS WIRE)--Akron BioProducts, a leading supplier of cGMP-compliant materials and technologies for cell and gene therapy manufacturing, today announced the launch of its Closed ...

MIAMI--(BUSINESS WIRE)--OrganaBio, LLC (“OrganaBio”) is expanding its product portfolio with the addition of current Good Manufacturing Practices (cGMP)- and current Good Tissue Practices ...

Market opportunities arise in providing solutions for cGMP software verification and validation, addressing increased FDA scrutiny. Demand exists for expertise in FDA guidelines, risk management ...

April 19, 2012. Suntron Corp., a provider of integrated electronics manufacturing systems (EMS) and embedded computing solutions, has announced that its Phoenix facility is now cGMP compliant and FDA ...

PALO ALTO, Calif., May 25, 2021 /PRNewswire/ -- I Peace, Inc. (CEO: Koji Tanabe), a Palo Alto-based biotech start-up focusing on Nobel Prize-winning technology "induced pluripotent stem cells (iPSCs)" ...

SAN DIEGO, Aug. 7, 2023 /PRNewswire/ -- NanoImaging Services ("NIS"), launches new cryo-transmission electron microscopy ("cryo-TEM") services to support biologics characterization with full GMP ...

CROs bring a depth of experience to the process of developing biologics, filling crucial gaps, reducing risks, and getting products to market quickly. This is of particular value to smaller biotech ...